CCA
ANNX icon

Column Capital Advisors’s Annexon ANNX Stock Holding History

Column Capital Advisors’s Portfolio ANNX Stock Details ANNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$342 Buy
+145
New +$439 ﹤0.01% 773

Other funds holding ANNX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Column Capital Advisors's ANNX Position: Q3 2023 in Review

Column Capital Advisors opened a new position in Annexon (ANNX) in Q3 2023: 145 shares worth $342. The stake represents ﹤0.01% of the portfolio and ranks #773 among its holdings.

93 funds tracked by Wall St. Rank hold ANNX as of Q3 2023.

  • Column Capital Advisors held 145 shares of Annexon worth $342 as of Q3 2023.
  • Annexon was a new Column Capital Advisors position in Q3 2023.
  • Annexon made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #773 holding.
  • 93 funds tracked by Wall St. Rank held Annexon as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.